Skip to content

Clinical trials

Completed Overweight trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Status: Completed Country / region: Germany Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20064
20073
20082
20093
20102
20115
20124
20131
20141
20161
20175
20186
201910
20204
20214
20222
20236
20247
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed76

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S13
InQpharm Group10
West German Center of Diabetes and Health5
German Institute of Human Nutrition4
Zealand Pharma4
Certmedica International GmbH3
Eli Lilly and Company3
Technical University of Munich3
AstraZeneca2
Novartis Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight76
Obesity59
Weight Loss14
Diabetes Mellitus, Type 29
Metabolic Syndrome8
Body Weight7
Metabolic Diseases4
Nutrition Disorders4
Diabetes Mellitus3
Hypercholesterolemia3

Trials

Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.